Peripheral stem cells are the preferred source of stem cells for autologous stem cell transplantation (ASCT) of young patients with MDS or AML following MDS: An analysis of the chronic leukaemia working party of the European blood and marrow transplantation group (EBMT).

被引：0
|
作者：
de Witte, T [1 ]
Brand, R [1 ]
van Biezen, A [1 ]
Delforge, M [1 ]
Runde, V [1 ]
Or, R [1 ]
Arcese, W [1 ]
Bandini, B [1 ]
Sierra, J [1 ]
Cahn, JY [1 ]
Michallet, M [1 ]
Amadori, S [1 ]
Niederwieser, D [1 ]
Gratwohl, A [1 ]
Laporte, JP [1 ]
机构：
[1] UMC Nijmegen, Nijmegen, Netherlands
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3523
引用
收藏
页码：848A / 849A
页数：2
相关论文
共 50 条
  • [1] Autologous and unrelated donor stem cell transplantation in MDS and secondary AML: A retrospective analysis on behalf of the chronic leukemia working party of the European group for blood and marrow transplantation (EBMT).
    Al-Ali, HK
    Brand, R
    van Biezen, A
    Finke, J
    Boogaerts, M
    Fauser, AA
    Egeler, M
    Cahn, JY
    Arnold, R
    Biersack, H
    de Witte, T
    Niederwieser, DW
    [J]. BLOOD, 2003, 102 (11) : 487A - 488A
  • [2] Prognostic factors in autologous stem cell transplantation (ASCT) for patients with MDS and AML following MDS
    de Witte, T
    van Biezen, A
    Hermans, J
    Laporte, JP
    Meloni, G
    Tura, S
    Holowiecki, J
    Boogaerts, M
    Marcus, R
    Mauri, SB
    Cahn, JY
    Diez-Martin, JL
    Niederwieser, D
    Gratwohl, A
    Apperley, J
    [J]. BONE MARROW TRANSPLANTATION, 1999, 23 : S154 - S154
  • [3] Allogeneic stem cell transplantation for adult chronic myelomonocytic leukaemia -: A report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
    Kröger, N
    Zabelina, T
    Guardiola, P
    Runde, V
    Sierra, J
    van Biezen, A
    Niederwieser, D
    Zander, A
    de Witte, T
    [J]. BONE MARROW TRANSPLANTATION, 2002, 29 : S54 - S55
  • [4] The impact of the source of stem cells on the outcome of Autologous Stem Cell Transplantation (ASCT) for patients with myelodysplastic syndrome or acute myeloid leukemia following MDS
    De Witte, T
    van Biezen, A
    Brand, R
    Laporte, J
    Meloni, G
    Tura, S
    Holowiecki, J
    Delforge, M
    Marcus, R
    Mauri, SB
    Cahn, J
    Diez-Martin, JL
    Niederwieser, D
    Gratwohl, A
    [J]. BONE MARROW TRANSPLANTATION, 2001, 27 : S70 - S70
  • [5] Autologous stem cell transplantation for treatment related MDS/AML. A report of the chronic leukemia working party (CLWP) of the EBMT.
    Kroger, N
    Brand, R
    van Biezen, A
    Zander, A
    Niederwieser, D
    de Witte, T
    [J]. BLOOD, 2003, 102 (11) : 43A - 43A
  • [6] Autologous stem cell transplantation (ASCT) for patients with poor risk MDS and secundary AML (sAML)
    De Witte, T
    Suciu, S
    Verhoef, G
    Labar, B
    Archimbaud, E
    Aul, C
    Selleslag, D
    Ferrant, A
    Wijermans, P
    Mandelli, F
    Amadori, S
    Jehn, U
    Muus, P
    DeMuynck, H
    Dardenne, M
    Zittoun, R
    Willemze, R
    Gratwohl, A
    Apperley, J
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 282 - 282
  • [7] Allogeneic stem cell transplantation for adult chronic myelomonocytic leukaemia. A report on behalf of the chronic leukaemia working party of the European group for blood and marrow transplantation (EBMT).
    Kroger, N
    Zabelina, T
    Guardiola, P
    Runde, V
    Sierra, J
    van Biezen, A
    Niederwieser, D
    Zander, A
    de Witte, T
    [J]. BLOOD, 2001, 98 (11) : 620A - 620A
  • [8] Allogeneic stem cell transplantation of adult chronic myelomonocytic leukaemia.: A report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
    Kröger, N
    Zabelina, T
    Guardiola, P
    Runde, V
    Sierra, J
    van Biezen, A
    Niederwieser, D
    Zander, AR
    de Witte, T
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2002, 118 (01) : 67 - 73
  • [9] Autologous peripheral stem cell transplantation of patients with high-risk MDS or AML following MDS results in equivalent outcome when compared to autologous bone marrow transplantation
    de Witte, T
    Brand, R
    van Biezen, A
    Cahn, J
    Laporte, J
    Arcese, W
    Bandin, B
    Michallet, M
    Sierra, J
    Goldstone, A
    Delforge, M
    Kröger, N
    Niederwieser, D
    [J]. BONE MARROW TRANSPLANTATION, 2003, 31 : S30 - S30
  • [10] Monosomal Karyotype Predicts Poor Outcome for MDS/sAML Patients with Chromosome 7 Abnormalities After Allogeneic Stem Cell Transplantation for MDS/sAML. A Study of the MDS Subcommittee of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
    Van Gelder, Michel
    Schetelig, Johannes
    Volin, Liisa
    Maertens, Johan
    Socie, Gerard
    Petersen, Eefke
    Thomssen, Henrike
    Biezen, Anja
    Brand, Ronald
    de Witte, T. M.
    Kroeger, Nicolaus
    [J]. BLOOD, 2009, 114 (22) : 123 - 124
12345